IgE synthesis by chronic lymphocytic leukemia cells.

The Journal of Experimental Medicine
M SarfatiG Delespesse

Abstract

The present results indicate that B cells isolated from chronic lymphocytic leukemia (B-CLL) from 11 of 14 patients are capable of specifically producing IgE upon costimulation with IL-4 and hydrocortisone (HC). IgE is detected by intracytoplasmic fluorescence staining and by RIA. Clinical, hematological, and immunological parameters (including Rai stage, WBC, Lc, sIg kappa/lambda, CD5, and CD23 expression) cannot distinguish the IgE responder from the nonresponder patients. IL-4 alone is a potent inducer of human IgE synthesis by normal PBMC and we show here that its effect is strikingly enhanced by HC. The IgE produced by B-CLLs are monoclonal since they display the same L chain type as the freshly isolated CD5+ B-CLLs. We, therefore, conclude that the combination of IL-4 and HC can abrogate the maturation arrest of CD5+ B-CLLs by inducing their differentiation into IgE-producing cells. The present data provide a unique model to study the isotype switching to IgE and the regulation of human IgE synthesis by monoclonal human B cells.

References

Dec 1, 1978·The Journal of Experimental Medicine·S M FuS R Harris
Feb 1, 1989·The Journal of Experimental Medicine·T MacKenzie, H M Dosch
Mar 1, 1989·Journal of Clinical Immunology·D Vercelli, R S Geha
Sep 1, 1988·The Journal of Experimental Medicine·D A Lebman, R L Coffman
Mar 1, 1987·New England and Regional Allergy Proceedings·A RayR E Rocklin
Dec 1, 1981·The Journal of Experimental Medicine·F K StevensonG T Stevenson
Feb 1, 1982·The Journal of Experimental Medicine·F Caligaris-CappioG Janossy

❮ Previous
Next ❯

Citations

Nov 1, 1993·Journal of Clinical Immunology·H G NüssleinM Gramatzki
Jan 1, 1995·Clinical Reviews in Allergy & Immunology·B A Chowdhury
Jan 1, 1990·Research in Immunology·G Delespesse, M Sarfati
Apr 1, 1989·Current Opinion in Immunology·G DelespesseC Heusser
Jan 1, 1991·Progress in Growth Factor Research·D W MaherG Morstyn
Nov 12, 2003·Pharmacology & Therapeutics·A M CollinsM R Edwards
Dec 1, 1991·Current Opinion in Immunology·J E de VriesH Yssel
Dec 22, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·C MooreR U Sorensen
Nov 9, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S S SalviS T Holgate
Nov 9, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Y J ChoH B Moon
Jun 18, 2002·Clinical and Experimental Immunology·D I MitsiasG Thyphronitis
Feb 1, 1996·Experimental Dermatology·I AebischerB M Stadler
Feb 1, 1992·Immunological Reviews·G DelespesseM Letellier
Jan 1, 1990·International Archives of Allergy and Applied Immunology·A FischerW König
Mar 1, 1991·The Journal of Clinical Investigation·C Y WuG Delespesse
Oct 1, 1996·The Journal of Clinical Investigation·F FaisN Chiorazzi
Jun 28, 2011·Leukemia & Lymphoma·Mark C Lanasa, J Brice Weinberg
Apr 1, 1995·The Journal of Allergy and Clinical Immunology·H H JabaraR S Geha
Dec 6, 1997·The Journal of Allergy and Clinical Immunology·T PulleritsJ Lötvall
Sep 1, 1991·The Journal of Allergy and Clinical Immunology·D Vercelli, R S Geha
Aug 1, 1994·The Journal of Allergy and Clinical Immunology·G ZiegD Y Leung
Nov 1, 1992·Clinical and Experimental Immunology·H G NüssleinJ R Kalden
Aug 1, 1994·European Journal of Immunology·I AebischerB M Stadler

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.